Shanghai Kaibao Pharmaceutical CO.,Ltd held its 1st Extraordinary General Meeting of 2023 on 22 December 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable, Mu Jingwei, non-independent director: Zhou Yingbin, non-independent director, Jing Shuzhong, non-independent director, Liu Jianzhong, non-independent director, Ren Liwang, non-independent director, Zhao Ningbo, non-independent director. Election and nomination of independent directors, cumulative voting system applicable: Ye Zuguang, independent director, Li Zhenni, independent director, Ma Hong, independent director.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.31 CNY | +0.48% | -0.32% | -5.11% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.11% | 908M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- 300039 Stock
- News Shanghai Kaibao Pharmaceutical CO.,Ltd
- Shanghai Kaibao Pharmaceutical CO.,Ltd Announces Executive Changes